Related Experiment Video
Updated: Apr 9, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Inhibition of Bilirubin Generation Exacerbates Oxidative Stress and Liver Injury in Early-to-Intermediate Obstructive
Pamela L Martín1, Geraldine L Hillotte1, María V Razori1
1Instituto de Fisiología Experimental (IFISE-CONICET), Rosario, Argentina.
Objective:
We have previously shown that hemeoxygenase-1 (HO1) induction and resulting elevation of bilirubin (BR) protects the liver from oxidative stress (OS)-induced acute cholestasis in vivo.
Aim:
To characterise the protective role of BR at the early-to-intermediate stages of obstructive cholestasis by investigating the consequences of inhibiting BR generation in vivo.
Methods:
Zinc protoporphyrin IX (ZnPP), a HO1 inhibitor, was administered 24 h before BDL to male Wistar rats. After confirming establishment of obstructive cholestasis and successful impairment in BR generation, we studied the impact of these interventions on redox status and histopathological features in liver tissue.
Results:
OS biomarkers were significantly elevated in ZnPP-pretreated BDL animals versus BDL-only controls, showing that under cholestatic conditions, oxidative damage is increased when BR production is impaired. Levels of antioxidant defences were lower in animals lacking BR generation, indicating that hepatic oxidative damage is more severe and antioxidant defences are weaker when BR production is inhibited. Histopathological analysis revealed significantly more severe obstructive injury in HO1-inhibited animals than in those subjected to BDL alone, indicating that BR generation impairment worsens the outcome of obstructive injury.
Conclusions:
The inhibition of HO1 and consequent decrease in the endogenous levels of BR negatively impacts the outcome of obstructive cholestasis due to the loss of BR's antioxidant and cytoprotective effects. BR accumulation during cholestasis serves as a critical defence against oxidative damage induced by retained bile salts.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Hepatic Drug Excretion: Influencing Factors
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

